Page 21 - ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஆய்வகங்கள் கண்புரை அறுவை சிகிச்சை சாதனங்கள் விற்பனை Today - Breaking & Trending Today
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / Levitee Labs Inc. (the "Company" or "Levitee"), a private British ....
Worldwide Respiratory Disease Testing Industry to 2026 - by Type, Application, End-user and Country February 17, 2021 07:08 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com s offering. The study predicts the short term and long term trends that can shape the future of the Respiratory Disease Testing market including the COVID-19 pandemic implications for the Respiratory Disease Testings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies. The Respiratory Disease Testing market forecast report identifies growth opportunities in the market and how companies are reacting to the current market condition ....
Perk Labs Inc.: Perk Labs Announces At-the-Market Equity Program Renewal NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / Perk Labs Inc. (CSE:PERK) ( Perk Labs or the Company ), the owner of Perk Hero, the all-in-one mobile ordering, contact-free payments and loyalty app, today announced that it has established an At-The-Market Equity Program (the ATM Program ) that allows the Company to periodically issue and sell up to C$4,000,000 worth of common shares in the capital of the Company (the Common Shares ) from treasury to the public, at the Company s discretion. All Common Shares sold under the ATM Program will be sold through the Canadian Securities Exchange or another Canadian marketplace (as defined in National Instrument 21-101 - ....
WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) has acquired cell sorting technology assets from Propel Labs, a unit of SIDIS Corp. The recently introduced Bigfoot Spectral Cell Sorter ....